Insider filing · LENZ
Versant Ventures VII GP-GP, LLC sold $6.5M of LENZ Therapeutics (LENZ)
Executed Jul 10 2025, disclosed Jul 14 2025, 4 days later.
Value, as filed
$6.5M
191,376 sh × $34.00
Executed
Jul 10 2025
the trade date, as filed
Disclosed
Jul 14 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
VL
Versant Ventures VII GP-GP, LLC
10% owner
profile →
Versant Ventures VII GP-GP, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $6.5M of LENZ (191,376 sh × $34.00, as filed), executed Jul 10 2025.
The name
LENZ
LENZ Therapeutics, Inc.
LENZ · Healthcare · 12 filings in 24 months
ticker →
Healthcare · LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→